Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 6/20 | 0.40 |
| ▸ | PPARG | P37231 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | FFAR1 | O14842 | 4/20 | 0.39 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.38 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1092846 | 0.83 | MAPT (0.47) | MAPTPPARGALDH1A1MAPK1FFAR1 | |
| SCHEMBL223024 | 0.83 | MAPT (0.47) | MAPTPPARGALDH1A1MAPK1FFAR1 | |
| SCHEMBL5653005 | 0.83 | MAPT (0.47) | MAPTPPARGALDH1A1MAPK1FFAR1 | |
| SCHEMBL6764754 | 0.81 | FFAR1 (0.40) | PPARGFFAR1 | |
| Hydrochloric Acid SCHEMBL6763546 | 0.80 | FFAR1 (0.40) | MAPTPPARGALDH1A1FFAR1HTT | |
| Hydrochloric Acid SCHEMBL6764128 | 0.80 | FFAR1 (0.40) | MAPTPPARGALDH1A1FFAR1HTT | |
| SCHEMBL3136982 | 0.79 | CUL4A (0.51) | MAPTALDH1A1ALOX12HTTLMNA | |
| Methoxymethane SCHEMBL5822675 | 0.79 | MAPT (0.48) | MAPTPPARGALDH1A1MAPK1FFAR1 | |
| SCHEMBL6095682 | 0.78 | MAPT (0.47) | MAPTPPARGALDH1A1MAPK1FFAR1 | |
| SCHEMBL13292851 | 0.78 | KMT2A (0.50) | MAPTALDH1A1MAPK1LMNAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040088799-A1 | Oxidation dyeing composition based on 1-(4-aminophenyl) pyrrolidines substituted in position 2 | L'OREAL S.A. (FR) | 2004-05-13 | — | — | US | disclosed |
| EP-1341509-A1 | OXIDATION DYEING COMPOSITION BASED ON 1-(4-AMINOPHENYL) PYRROLIDINES SUBSTITUTED IN POSITION 2 | L'OREAL (FR) | 2003-09-10 | — | — | EP | disclosed |
| WO-2002045670-A1 | OXIDATION DYEING COMPOSITION BASED ON 1-(4-AMINOPHENYL) PYRROLIDINES SUBSTITUTED IN POSITION 2 | L'OREAL (FR) | 2002-06-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040088799-A1 | Oxidation dyeing composition based on 1-(4-aminophenyl) pyrrolidines substituted in position 2 | PYCR1, COX5A, COX5B | MAPT 1001/4885PPARG 3267/4885ALDH1A1 195/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.